- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT06771531
Hirnstimulation für die Fußsohlenwahrnehmung bei älteren Erwachsenen mit somatosensorischen Defiziten der Fußsohle (BSFS)
Kortikale Mechanismen und Modulation der Somatosensation bei älteren Erwachsenen mit somatosensorischen Beeinträchtigungen der Fußsohle
In older adults, diminished sensation of the legs and feet is highly prevalent and causes poor balance and reduced mobility. This type of sensation is not only dependent upon the receptors and nerves in the legs and feet, but also upon a complex central nervous system pathway that includes the cerebral cortex of the brain. This project will use a form of noninvasive brain stimulation called transcranial direct current stimulation (tDCS) to test whether increasing the excitability of the brain networks that process sensory feedback can augment foot sole sensation, balance, and mobility in older adults suffering from mild-to-moderate foot sole sensory impairments.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Junhong Zhou, PhD
- Telefonnummer: 617-971-5346
- E-Mail: junhongzhou@hsl.harvard.edu
Studienorte
-
-
Massachusetts
-
Roslindale, Massachusetts, Vereinigte Staaten, 02131
- Rekrutierung
- Hebrew SeniorLife
-
Kontakt:
- Kathy Tasker
- Telefonnummer: 617-971-5351
- E-Mail: KathyTasker@hsl.harvard.edu
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Aged ≥65 years.
- Self-reported feeling of unsteadiness or difficulty when standing and walking.
- Mild-to-moderate foot-sole somatosensory impairment: the ability to perceive 75g monofilament but inability to perceive 10g monofilament.
Exclusion Criteria:
- self-reported inability to stand or walk continuously for one minute without personal assistance (canes or walkers allowed);
- history or presence of foot ulceration, amputation, or deformities;
- self-reported uncontrolled pain or pain that is associated with mobility disability;
- uncontrolled diabetes mellitus;
- hospitalization within the past three months due to acute illness, or as the result of a musculoskeletal injury significantly affecting balance;
- persistent severe pain of lower extremity when standing or walking;
- diagnosis of dementia, Parkinson's disease, or stroke that affects balance;
- unstable medical condition;
- legal blindness or deafness;
- uncontrolled hypertension (i.e., systolic BP >180, diastolic BP >100 mm Hg, or prescription of ≥3 anti-hypertensive medications);
- functionally limiting nephropathy, severe diseases or transplant of the kidney or liver, renal or congestive heart failure;
- active cancer treatment;
- balance disorders due to past use of chemotherapy or history of Guillain-Barré syndrome;
- use of neuro-active or recreational drugs (e.g., sedatives, anti-psychotics), or alcohol abuse, which may affect the brain excitability;
- contraindications to MRI or tDCS (e.g., personal or family history of seizures or epilepsy, metallic or electric bio-implants, claustrophobia, brain surgery);
- persistent vertigo;
- history of Charcot-Marie-Tooth nerve disease.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Crossover-Aufgabe
- Maskierung: Verdreifachen
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: tDCS group
Participants in this arm will receive the real tDCS intervention. |
tDCS can safely and selectively modulate cortical excitability (specifically neuronal firing likelihood) by transferring weak electrical currents between scalp electrodes. The direct current delivered by any one electrode will not exceed 2.0 mA and the total amount of current from all electrodes will not exceed 4 mA in this study. |
|
Schein-Komparator: sham group
Participants in this arm will receive the sham stimulation as control. |
sham stimulation will implement the same protocol of the tDCS intervention; however, only very low-level currents (no more than 0.5 mA) are transferred between the same electrodes used for the tDCS throughout the 20-minute session. This strategy effectively mimics the cutaneous sensations and skin redness induced by creating only micro cortical electric fields. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
postural sway area when standing with eyes closed on the foam
Zeitfenster: Before and immediately after intervention
|
This metric assesses the degree to which the soft support and cut-off of the vision diminishes the control of standing posture. |
Before and immediately after intervention
|
|
Timed Up-and-Go (TUG) time
Zeitfenster: Before and immediately after intervention
|
This metric assesses mobility. |
Before and immediately after intervention
|
|
On-target Blood oxygen level dependent (BOLD) signal intensity in response to foot sole stimulation
Zeitfenster: Before and immediately after intervention
|
This metric assesses the degree to which brain cortical regions activated by the walking-related foot-sole stimulation. |
Before and immediately after intervention
|
|
Standing vibratory thresholds of each foot sole
Zeitfenster: Before and immediately after intervention
|
This metric assesses the degree to which the foot soles can sense the vibro-tactile stimuli when standing. |
Before and immediately after intervention
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Postural sway speed when standing with eyes closed on the foam
Zeitfenster: Before and immediately after intervention
|
This metric assesses the degree to which the soft support and cut-off of the vision diminishes the control of standing posture. |
Before and immediately after intervention
|
|
Gait speed of 10m walking test
Zeitfenster: Before and immediately after intervention
|
This metric assesses mobility. |
Before and immediately after intervention
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
BOLD signal intensity within other relevant cortical regions in response to foot sole stimulation
Zeitfenster: Before and immediately after intervention
|
This metric assesses the degree to which brain cortical regions activated by the walking-related foot-sole stimulation. |
Before and immediately after intervention
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- Pro00044674
- K01AG075180 (US NIH Stipendium/Vertrag)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .